Time: 2 pm
(Eastern Time (ET))
Speaker: Dr Heather Leitch
Topic: Latest research on MDS
To register:
THE SPEAKER:
Dr. Heather Leitch, Director Hematology/Oncology Research (SPH), Clinical Professor, St. Paul’s Hospital
Dr. Heather Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Associate Professor at UBC. Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma.
Tue Aug 4, 2020, 01:31 PM
Similar Threads
